Sophia Gailhardou

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

Sri Rezeki Hadinegoro, José Luis Arredondo-Garcı́a, Maria Rosario Capeding et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

Kulkanya Chokephaibulkit, Chukiat Sirivichayakul, Usa Thisyakorn et al. · The Pediatric Infectious Disease Journal · 2010 · 75 citations

Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America

Sri Rezeki Hadinegoro, Humberto Reynales, Mary Noreen Chua et al. · Clinical Microbiology and Infection · 2018 · 65 citations · Full text

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials

Sophia Gailhardou, Anna Skipetrova, Gustavo H. Dayan et al. · PLoS neglected tropical diseases · 2016 · 52 citations · Full text

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

Emmanuel Feroldi, Chitsanu Pancharoen, Pope Kosalaraksa et al. · Human Vaccines & Immunotherapeutics · 2012 · 44 citations · Full text